Morgan Stanley’s Opthea Limited American Depositary Shares OPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-765
Closed -$2.57K – 8570
2025
Q3
$2.57K Hold
765
– – ﹤0.01% 7258
2025
Q2
$2.57K Hold
765
– – ﹤0.01% 7174
2025
Q1
$2.61K Sell
765
-2,600
-77% -$11.5K ﹤0.01% 7121
2024
Q4
$13.2K Buy
+3,365
New +$13.4K ﹤0.01% 6705
2024
Q2
– Sell
-21
Closed -$86 – 8105
2024
Q1
$86 Sell
21
-979
-98% -$3.07K ﹤0.01% 7387
2023
Q4
$2.95K Hold
1,000
– – ﹤0.01% 6964
2023
Q3
$1.74K Hold
1,000
– – ﹤0.01% 7152
2023
Q2
$2.8K Hold
1,000
– – ﹤0.01% 7121
2023
Q1
$3.95K Hold
1,000
– – ﹤0.01% 7113
2022
Q4
$5.36K Hold
1,000
– – ﹤0.01% 7131
2022
Q3
$6K Hold
1,000
– – ﹤0.01% 7237
2022
Q2
$6K Hold
1,000
– – ﹤0.01% 7387
2022
Q1
$6K Hold
1,000
– – ﹤0.01% 7562
2021
Q4
$8K Buy
+1,000
New +$7.31K ﹤0.01% 7557
2021
Q3
– Sell
-32
Closed – – 8300
2021
Q2
$0 Buy
+32
New +$285 ﹤0.01% 8030

Morgan Stanley's OPT Position: Q4 2025 in Review

Morgan Stanley sold out of Opthea Limited American Depositary Shares (OPT) in Q4 2025, closing a stake of 765 shares — an estimated $2.57K sold.

Morgan Stanley first reported a position in OPT in Q2 2021 and held it in 15 quarters. The position peaked at $13.2K in Q4 2024. 0 funds tracked by Wall St. Rank hold OPT as of Q4 2025.

  • Morgan Stanley reported no remaining Opthea Limited American Depositary Shares position as of Q4 2025 after selling out during the quarter.
  • Morgan Stanley sold 765 Opthea Limited American Depositary Shares shares in Q4 2025, an estimated $2.57K.
  • Morgan Stanley first reported a position in Opthea Limited American Depositary Shares in Q2 2021 and held it in 15 quarters.
  • Morgan Stanley's Opthea Limited American Depositary Shares position peaked at $13.2K in Q4 2024.
  • 0 funds tracked by Wall St. Rank held Opthea Limited American Depositary Shares as of Q4 2025.

Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.